Francesca Barone

2022

In 2022, Francesca Barone earned a total compensation of $908.3K as Chief Scientific Officer at Candel Therapeutics, a 149% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$144,522
Option Awards$233,988
Salary$362,192
Stock Awards$155,400
Other$12,200
Total$908,302

Barone received $362.2K in salary, accounting for 40% of the total pay in 2022.

Barone also received $144.5K in non-equity incentive plan, $234K in option awards, $155.4K in stock awards and $12.2K in other compensation.

Rankings

In 2022, Francesca Barone's compensation ranked 3,237th out of 5,736 executives tracked by ExecPay. In other words, Barone earned more than 43.6% of executives.

ClassificationRankingPercentile
All
3,237
out of 5,736
44th
Division
Manufacturing
1,820
out of 3,125
42nd
Major group
Chemicals And Allied Products
867
out of 1,416
39th
Industry group
Drugs
811
out of 1,317
38th
Industry
Biological Products, Except Diagnostic Substances
196
out of 291
33rd
Source: SEC filing on May 23, 2023.

Barone's colleagues

We found two more compensation records of executives who worked with Francesca Barone at Candel Therapeutics in 2022.

2022

Paul FMedSci

Candel Therapeutics

Chief Executive Officer

2022

Seshu RAC

Candel Therapeutics

Chief Technical and Development Officer

News

You may also like